Literature DB >> 16311158

A case with cholinesterase inhibitor responsive asymmetric posterior cortical atrophy.

Eunhee Kim1, Yunsoo Lee, Jongkeol Lee, Seol-Heui Han.   

Abstract

A 55-year-old right-handed woman presented initially with mild amnestic and depressive episodes but slowly developed progressive neurobehavioral symptoms, indicative of posterior cortical atrophy in ensuing years. A more detailed neurobehavioral test suggested predominant right temporo-parietal dysfunction with executive functional deficits. SPECT and MRI findings revealed right unilateral temporo-parietal involvement. Cholinesterase inhibitor administration led to amelioration of symptoms. We suggest that cases of posterior cortical atrophy or visual variant of Alzheimer's disease may be responsive to cholinesterase inhibitor therapy; however, the observation in a single case should be confirmed on larger populations in a clinical trial design with placebo control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311158     DOI: 10.1016/j.clineuro.2004.11.022

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

1.  Imaging correlates of posterior cortical atrophy.

Authors:  Jennifer L Whitwell; Clifford R Jack; Kejal Kantarci; Stephen D Weigand; Bradley F Boeve; David S Knopman; Daniel A Drubach; David F Tang-Wai; Ronald C Petersen; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2006-06-23       Impact factor: 4.673

2.  [Posterior cortical atrophy. Pathology, diagnosis and treatment of a rare form of dementia].

Authors:  M Ortner; A Kurz
Journal:  Nervenarzt       Date:  2015-07       Impact factor: 1.214

Review 3.  Posterior Cortical Atrophy.

Authors:  Jonathan M Schott; Sebastian J Crutch
Journal:  Continuum (Minneap Minn)       Date:  2019-02

4.  Visual impairment and posterior cortical atrophy preceding rapid progressive dementia.

Authors:  Kai Ivar Müller; Svein Ivar Bekkelund
Journal:  BMJ Case Rep       Date:  2013-01-02

5.  Prodromal posterior cortical atrophy: clinical, neuropsychological, and radiological correlation.

Authors:  Lung Tat Andrew Chan; Whitney Lynch; Mary De May; Jonathan C Horton; Bruce L Miller; Gil D Rabinovici
Journal:  Neurocase       Date:  2013-12-05       Impact factor: 0.881

Review 6.  Posterior cortical atrophy.

Authors:  Sebastian J Crutch; Manja Lehmann; Jonathan M Schott; Gil D Rabinovici; Martin N Rossor; Nick C Fox
Journal:  Lancet Neurol       Date:  2012-02       Impact factor: 44.182

7.  Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy.

Authors:  Andrea Arighi; Mario Rango; Marco Bozzali; Anna M Pietroboni; Giorgio Fumagalli; Laura Ghezzi; Chiara Fenoglio; Pietro R Biondetti; Nereo Bresolin; Daniela Galimberti; Elio Scarpini
Journal:  PLoS One       Date:  2015-10-19       Impact factor: 3.240

8.  A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study.

Authors:  Basil H Ridha; Sebastian Crutch; Dawn Cutler; Christopher Frost; William Knight; Suzie Barker; Norah Epie; Elizabeth K Warrington; Riitta Kukkastenvehmas; Jane Douglas; Martin N Rossor
Journal:  Alzheimers Res Ther       Date:  2018-05-01       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.